nascobal Drug Patent Profile
✉ Email this page to a colleague
When do Nascobal patents expire, and when can generic versions of Nascobal launch?
Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. There are six patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nascobal
A generic version of nascobal was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for nascobal?
- What are the global sales for nascobal?
- What is Average Wholesale Price for nascobal?
Summary for nascobal
US Patents: | 6 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 1 |
Patent Applications: | 57 |
Drug Prices: | Drug price information for nascobal |
Drug Sales Revenues: | Drug sales revenues for nascobal |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for nascobal |
What excipients (inactive ingredients) are in nascobal? | nascobal excipients list |
DailyMed Link: | nascobal at DailyMed |
![nascobal drug patent expirations Drug patent expirations by year for nascobal](/p/graph/s/t/nascobal-patent-expirations.png)
![Drug Prices for nascobal](/p/graph/drug-price/nascobal.png)
![Drug Sales Revenue Trends for nascobal](/p/graph/drug-sales-revenues/nascobal.png)
Recent Clinical Trials for nascobal
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Swedish Orphan Biovitrum | Phase 1 |
Pharmacology for nascobal
Drug Class | Vitamin B12 |
Paragraph IV (Patent) Challenges for NASCOBAL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NASCOBAL | Nasal Spray | cyanocobalamin | 500 mcg/spray | 021642 | 1 | 2017-04-28 |
US Patents and Regulatory Information for nascobal
nascobal is protected by six US patents.
Patents protecting nascobal
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF CYANOCOBALAMIN
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: NASAL ADMINISTRATION OF CYANOCOBALAMIN
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION
Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SUPPLEMENT FOR VITAMIN B12 DEFICIENCIES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Pharm | NASCOBAL | cyanocobalamin | GEL, METERED;NASAL | 019722-001 | Nov 5, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for nascobal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Par Pharm | NASCOBAL | cyanocobalamin | GEL, METERED;NASAL | 019722-001 | Nov 5, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for nascobal
See the table below for patents covering nascobal around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 5775786 | ⤷ Sign Up | |
Hungary | T43493 | ⤷ Sign Up | |
European Patent Office | 0216917 | NASAL COMPOSITIONS CONTAINING VITAMIN B 12 | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |